Below you will find a collection of articles from Hematology, the ASH Education Program, written by experts in the field about the use of bone marrow and hematopoietic stem cell transplants for the treatment of a number of blood disorders, including leukemias, myelodysplastic and myeloproliferative disorders, lymphomas, multiple myeloma, and amyloidosis. Complications of the procedure, such as chronic graft-versus-host disease and other late effects, are also explored. Additionally, information about donating bone marrow for transplants, as well as links to other organizations that facilitate marrow donations or transplantation research, are available on this website.

General Information

• Allogeneic Immunotherapy to Optimize the Graft-versus-Tumor Effect: Concepts and Controversies (2011) 
• Complications, Diagnosis, Management, and Prevention of CMV Infections: Current and Future (2011) 
• Posttransplantation Vaccination: Concepts Today and on the Horizon (2011) 
• Long-Term Physiological Side Effects After Allogeneic Bone Marrow Transplantation (2010) 
• Comorbidities and Hematopoietic Cell Transplantation Outcomes (2010) 
• Health-Related Quality of Life Following Allogeneic Hematopoietic Stem Cell Transplantation (2010) 
• Transplantation in Adult ALL (2009) 
• Allotransplantation for Chronic Lymphocytic Leukemia (2009) 
• Allogeneic Stem Cell Transplantation in Follicular Lymphoma: Recent Progress and Controversy (2009) 
• ASH Evidence-Based Guidelines: Is There a Role for Second Allogeneic Transplant After Relapse? (2009) 
• Gene Replacement Therapy for Sickle Cell Disease and Other Blood Disorders (2008) 
• Epigenetic Modulation and Other Options to Improve Outcome of Stem Cell Transplanation in MDS (2008) 
• Does High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation Have a Role in the Primary Treatment of Peripheral T-Cell Lymphomas? (2008) 
• Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia When a Matched Related Donor Is Not Available (2008) 
• Reduced-Intensity Stem Cell Transplantation: "...whereof a little More than a little is by much too much." King Henry IV, part 1, I, 2 (2007) 
• Umbilical Cord Blood (UCB) Transplantation: An Alternative to the Use of Unrelated Volunteer Donors? (2007) 
• GVHD—The Nuts and Bolts (2007) 

Leukemias and Myelodysplastic/Myeloproliferative Disorders

• Current Treatment of Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia (2011) 
• Novel Approaches to the Treatment of Acute Myeloid Leukemia (2011) 
• Allogeneic Hematopoietic Stem-Cell Transplantation for Myelodysplastic Syndrome (2010) 
• Evidence-Based Mini-Review: Should Patients Over the Age of 60 with INT-2 or High-Risk Myelodysplastic Syndrome Undergo Allogeneic Stem Cell Transplantation Prior to Progression to Acute Myelogenous Leukemia? (2010) 
• The Changing Classification of Myelodysplastic Syndromes: What’s in a Name? (2009) 
• Treatment of MDS: Something Old, Something New, Something Borrowed... (2009) 
• Supportive Care and Chelation Therapy in MDS: Are We Saving Lives or Just Lowering Iron? (2009) 
• Epigenetic Modulation and Other Options to Improve Outcome of Stem Cell Transplantation in MDS (2008) 

Lymphomas

• Allogeneic Stem Cell Transplantation In Follicular Lymphoma: Recent Progress and Controversy (2009) 
• Novel Therapies and Role of Transplant in the Treatment of Peripheral T-Cell Lymphomas (2008) 
• Management of Hodgkin Lymphoma in Relapse after Autologous Stem Cell Transplant (2008) 

Plasma Cell Disorders

• Stem Cell Transplantation for Multiple Myeloma: Current and Future Status (2011) 
• What is the Benefit of Maintenance Therapy with Lenalidomide or Bortezomib after Autologous Stem Cell Transplantation in Multiple Myeloma and What is the Risk of Developing a Secondary Primary Malignancy? (2011) 
• How to Treat a Newly Diagnosed Young Patient With Multiple Myeloma (2009) 

Other Disorders

• Hematopoietic Stem Cell Transplantation for Sickle Cell Disease: Current Practice and Emerging Trends (2011)  
• Stem Cell Transplantation in Inherited Metabolic Disorders (2011) 
• Successes and Failures of Stem Cell Transplantation in Autoimmune Diseases (2011) 
• Therapy for Aplastic Anemia (2011) 
• Alternative Donor Transplantation for Aplastic Anemia (2010) 
• Hematopoietic Stem Cell Transplantation in Thalassemia (2010) 
• Reduced-Intensity Regimens in Allogeneic Hematopoietic Stem Cell Transplantation for Hemoglobinopathies (2006) 

Late Effects

• Long-Term Physiological Side Effects After Allogeneic Bone Marrow Transplantation (2010) 
• Health-Related Quality of Life Following Allogeneic Hematopoietic Stem Cell Transplantation (2010) 
• Late Critical Problems in Transplantation: An Historical Perspective (2008) 
• Late Pulmonary, Cardiovascular, and Renal Complications after Hematopoietic Stem Cell Transplantation and Recommended Screening Practices (2008) 
• Recognizing and Managing Chronic Graft-Versus-Host Disease (2008) 
• Old and New Cancers after Hematopoietic-Cell Transplantation (2008) 

back to top